Binding crevice for TT-232 in a homology model of type 1 somatostatin receptor

Biochemical and Biophysical Research Communications

Volumn 316, Issue 4, 2004, Pages 1059-1064

  Simon, Ágnes ^a   Czajlik, András ^b   Perczel, András ^b   Kéri, György ^c   Nyikos, Lajos ^a   Emri, Zsuzsa ^a   Kardos, Julianna ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Homology model; NMR; Somatostatin receptor; TT 232 binding; TT 232 conformation

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLCYSTEINYLTHREONINAMIDE 2,6 DISULFIDE; GLUTAMINE; PHENYLALANINE; SERINE; SOMATOSTATIN RECEPTOR 1; TYROSINE; VALINE;

ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONFORMATION; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RACEMIC MIXTURE; RAT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BINDING SITES; COMPUTER SIMULATION; CONSENSUS SEQUENCE; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, SOMATOSTATIN; RHODOPSIN; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; WATER;

BOVINAE;

EID: 1642267370     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.161     Document Type: Article

References (27)

1. Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27:1986;63-100.
2. de Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.L., Dunlop C.L.M., Siggins G.L., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 381:1996;242-245.
3. Boehm S., Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17:1997;4066-4075.
4. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 289:2000;739-745.
5. Kéri G., Mezö I., Horváth A., Vadász Z., Balogh A., Idei M., Vantus T., Teplán I., Mák M., Horváth J., Pál K., Csuka O. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity. Biochem. Biophys. Res. Commun. 191:1993;681-687.
6. Szende B., Horvath A., Bökönyi G., Kéri G. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma. Br. J. Cancer. 88:2003;132-136.
7. Pintér E., Helyes Zs., Németh J., Porszász R., Pethö G., Than M., Kéri G., Horváth A., Jakab B., Szolcsányi J. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia. Naunyn Schmiedebergs Arch. Pharmacol. 366:2002;142-150.
8. Steták A., Csermely P., Ullrich A., Kéri G. Physical and functional interactions between protein tyrosine phosphatase alpha, PI 3-kinase, and PKCdelta. Biochem. Biophys. Res. Commun. 288:2001;564-572.
9. Selmer I.-S., Schindler M., Allen J.P., Humphrey P.P.A., Emson P.C. Advances in understanding neuronal somatostatin receptors. Regulatory Pept. 90:2000;1-18.
10. Ballesteros A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25:1995;366-428.
11. Peitsch M.C. Protein modeling by E-mail. Bio/Technology. 13:1995;658-660.
12. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis. 18:1997;2714-2723.
13. Schwede T., Kopp J., Guex N., Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:2003;3381-3385.
14. Subramanian G., Paterlini M.G., Portoghese P.S., Ferguson D.M. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J. Med. Chem. 43:2000;381-391.
15. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19:1998;1639-1662.
16. Patel Y.C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20:1999;157-198.
17. Nyitrai G., Kékesi A.K., Emri Zs., Szárics É., Juhász G., Kardos J. GABA(B) receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro. Eur. J. Pharmacol. 478:2003;111-119.
18. Jaspers H., Horváth A., Mezö I., Kéri G., Van Binst G. Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity. Int. J. Peptide Protein Res. 43:1994;271-276.
19. Li H., Jiang X., Howell B.S., Goodman M. Synthesis, conformational analysis and bioactivity of Lan-7, a lanthionine analog of TT-232. J. Pept. Sci. 6:2000;26-35.
20. Janecka A., Zubrzycka M., Janecki T. Somatostatin analogs. J. Pept. Res. 58:2001;91-107.
21. Jiang S., Gazal S., Gelerman G., Ziv O., Karpov O., Litman P., Bracha M., Afargan M., Gilon C., Goodman M. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution. J. Pept. Sci. 7:2001;521-528.
22. Kaupmann K., Bruns C., Raulf F., Weber H.P., Mattes H., Lubbert H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J. 14:1995;727-735.
23. Bissantz C., Bernard P., Hibert M., Rognan D. Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins. 50:2003;5-25.
24. Ballesteros J.A., Shi L., Javitch J.A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60:2001;1-19. Erratum in: 61 (2002) Mol. Pharmacol. 247.
25. Armstrong N., Sun Y., Chen G.-Q., Gouaux E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature. 395:1998;913-917.
26. Armstrong N., Gouaux E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron. 28:2000;165-181.
27. Nyikos L., Simon Á., Barabas P., Kardos J. Ligand-specific conformations of an ionotropic glutamate receptor. Protein Eng. 15:2002;717-720.